"Mesalamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
| Descriptor ID |
D019804
|
| MeSH Number(s) |
D02.241.223.100.050.300.500 D02.241.223.100.300.595.100.540 D02.241.511.390.595.100.540 D02.455.426.559.389.127.020.452.750 D02.455.426.559.389.127.281.595.100.540 D02.455.426.559.389.657.410.595.100.540
|
| Concept/Terms |
Mesalamine- Mesalamine
- Mesalazine
- m-Aminosalicylic Acid
- m Aminosalicylic Acid
- 5-Aminosalicylic Acid
- 5 Aminosalicylic Acid
- meta-Aminosalicylic Acid
- meta Aminosalicylic Acid
|
Below are MeSH descriptors whose meaning is more general than "Mesalamine".
Below are MeSH descriptors whose meaning is more specific than "Mesalamine".
This graph shows the total number of publications written about "Mesalamine" by people in this website by year, and whether "Mesalamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 0 | 1 |
| 2017 | 7 | 5 | 12 |
| 2018 | 4 | 4 | 8 |
| 2019 | 3 | 0 | 3 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Mesalamine" by people in Profiles.
-
A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD. Sci Rep. 2021 08 13; 11(1):16522.
-
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Gut. 2021 10; 70(10):2020-2022.
-
COVID-19 in IBD: The experience of a single tertiary IBD center. Dig Liver Dis. 2021 03; 53(3):271-276.
-
De-escalation of medical therapy in inflammatory bowel disease. Curr Opin Pharmacol. 2020 12; 55:73-81.
-
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clin Gastroenterol Hepatol. 2021 02; 19(2):394-396.e5.
-
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020 06; 69(6):1148-1149.
-
Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis. Br J Clin Pharmacol. 2019 10; 85(10):2244-2254.
-
Plasma N-terminal pro-B-type natriuretic peptide (BNP) in mesalazine-induced myopericarditis. BMJ Case Rep. 2019 Apr 11; 12(4).
-
Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid-Derived Drugs. Pancreas. 2019 04; 48(4):488-495.
-
Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: A novel approach in treating ulcerative colitis. Int J Biol Macromol. 2019 Apr 01; 126:427-435.